Recursion Pharmaceuticals Inc (RXRX)

NASDAQ HEALTHCARE
$3.30 -3.23% RSI 50 Neutral Add Alert

Moving Averages

SMA 200
$4.70
Price below

Company Profile

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that decodes biology by integrating technological innovations in biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company is headquartered in Salt Lake City, Utah.

Sector
HEALTHCARE
Industry
BIOTECHNOLOGY
Market Cap
$1.75B
P/E Ratio
None
EPS
$-1.41
Beta
1.013
Dividend Yield
0.00%
52-Week High
$7.18
52-Week Low
$2.8

Similar stocks in BIOTECHNOLOGY

BNTX
BioNTech SE
RSI 54.0
VRTX
Vertex Pharmaceuticals Inc
RSI 37.0
CRSP
CRISPR Therapeutics AG
RSI 46.0
MRNA
Moderna Inc
RSI 35.0
VKTX
Viking Therapeutics Inc
RSI 39.0
SRPT
Sarepta Therapeutics Inc
RSI 50.0

Data last updated: April 10, 2026 at 9:50 PM EDT

Track RXRX for free

Get e-mail RSI alerts when Recursion Pharmaceuticals Inc enters oversold or overbought territory. Free forever.

Add Alert